Low Serum or Plasma Glucose – Hypoglycemia
Reactive hypoglycemia is usually observed in diabetics but also is found in nondiabetics following ingestion of a high-carbohydrate meal.
Pts w/ hypoglycemia caused by an insulin-producing tumor may have signs & symptoms associated w/ malignancy.
For surreptitious insulin injection, seek a history of insulin use or access to insulin.
For excess administration of sulfonylurea drugs, seek a history of use of or access to these drugs.
For impaired liver function, seek clinical evidence of impaired liver function.
Suggested Additional Lab Testing
Blood glucose level <50 mg/dL, coincident w/ symptoms that are reversible within 15 to 45 min of the administration of glucose in the absence of cerebral edema
C-peptide level. Pts have high levels of insulin synthesis & secretion of this portion of the pro-insulin molecule should be detectable in the blood at high levels
Elevated blood insulin Surreptitious insulin administration: insulin is elevated but C-peptide level is not because the insulin in the blood was not synthesized from proinsulin in the pt's pancreas.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- A Ketogenic Diet as an Adjunct to Cancer Treatment
- Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
- Blinatumomab-Ponatinib Salvage Therapy in B-Cell Acute Lymphoblastic Leukemia: Case Report of Benefit
- FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Adding Chemotherapy to Radiation Post-Radical Cystectomy Improves Survival in Urothelial Carcinoma
- Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer